ITT reports Q1 2026 results on May 6 with a notable shift in short positioning — sellers have been quietly rebuilding exposure after a sharp drop in late March, and the options market has just swung to its least defensive reading in months.
Short interest tells the more charged side of the story heading into Wednesday's print. At 7% of the free float — up roughly 10% over the past month — the short position has grown meaningfully, driven by a jump from around 3.3 million shares in late March to over 5.4 million currently. That build accelerated through April. Yet the lending market shows no sign of stress: borrowing costs have more than halved over the past month to just 0.33%, and availability remains loose. The borrow is cheap and plentiful, which means the short rebuild reflects a considered directional bet rather than a crowded or squeezed trade.
Options positioning tells a different story, and the contrast is striking. The put/call ratio has dropped to 1.04 — now running well below its 20-day average of 1.33, a full standard deviation lower. That marks a sharp reversal from mid-April, when the PCR briefly touched 1.79 amid broad market anxiety. Options traders have stepped off the brakes. The two signals — rising short interest alongside easing defensive options posturing — are pulling in opposite directions, which makes the setup harder to read than most going into a print.
The analyst community leans constructive, though with some recent tempering. The mean price target of roughly $236 sits about 12% above the current price of $209.89, and several firms hold Buy ratings with targets in the $228–$245 range. Barclays moved to the sidelines in early April, trimming its target to $210 from $220 while holding an Equal-Weight, a signal that one part of the Street sees limited near-term upside from current levels. The bull case rests on the Svanehoj backlog — up 52% with a 1.2x book-to-bill — and aerospace and defence strength. Bears point to margin pressure: adjusted operating margins projected near 18.9% for 2026 with further compression expected in 2027, plus tariff exposure and raw-material cost risk across segments. EPS momentum ranks in the top quintile of the universe on both 30-day and 90-day horizons, and the forward EPS growth score ranks in the 89th percentile — numbers that underpin the bull case but also raise the bar for the print itself.
Institutional holders added shares broadly in Q1: Capital Research, Vanguard, and BlackRock all grew positions, each adding between 500,000 and 630,000 shares by March 31. CEO Luca Savi sold approximately $12.1 million worth of stock in early March — a material transaction, though timed before the recent recovery in the share price from the mid-$180s. The stock closed at $209.89, down about 4% on the week and 2% on Friday alone, diverging from peers like CAT, which gained 7% on the week, while FLS fell 14% — a mixed backdrop in the industrial machinery space that leaves ITT without a clear peer read into the release.
Wednesday's print will test whether the Svanehoj backlog and aerospace tailwinds are translating into earnings momentum strong enough to justify the recent re-rating, or whether margin compression concerns carry more weight than the headline growth numbers suggest.
See the live data behind this article on ORTEX.
Open ITT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.